Research progress on pharmacogenomics of anti-cancer drugs

Research progress on pharmacogenomics plays an important role in aspects such as guiding individualized medication in clinical setting and illustrating difference between individuals. Commonly anti-cancer drugs in the treatment of tumor in the highest frequency of use, is the preferred first-line drugs regimen.Through analysis and research on pharmacogenomics of commonly anti-cancer drugs, differences of the genetic level between patients are identified with the aim of predicting effects of chemotherapy, determining optimal dosage and reducing adverse reaction. As a result, true individualized medication can be realized.